{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:50:32Z","timestamp":1789426232470,"version":"build-2803163510"},"reference-count":80,"publisher":"The Endocrine Society","issue":"12","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK043006-46"],"award-info":[{"award-number":["DK043006-46"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Hyperparathyroidism-jaw tumor (HPT-JT) syndrome is a heritable form of primary hyperparathyroidism caused by germline inactivating mutations in CDC73 encoding parafibromin and is associated with an increased risk of parathyroid cancer. There is little evidence to guide the management of patients with the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>(1) Characterize the natural history of HPT-JT, (2) correlate genotype and histology of parathyroid tumors with parafibromin immunostaining, (3) understand molecular changes downstream to CDC73 loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective study of patients with HPT-JT syndrome (genetically confirmed or affected first-degree relatives). Independent review of uterine tumor from 2 patients and staining for parafibromin on parathyroid tumors from 19 patients (13 adenomas, 6 carcinomas) was performed. RNA-sequencing was performed in 21 parathyroid samples (8 HPT-JT-related adenomas, 6 HPT-JT-related carcinomas, and 7 sporadic carcinomas with wild-type CDC73).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 68 patients from 29 kindreds with HPT-JT with median age at last follow-up of 39 [interquartile range, 29-53] years. A total of 55\/68 (81%) developed primary hyperparathyroidism; 17\/55 (31%) had parathyroid carcinoma. Twelve of 32 (38%) females developed uterine tumors. Of the 11 patients who had surgical resection for uterine tumors, 12\/24 (50%) tumors were rare mixed epithelial mesenchymal polypoid lesions. Four of 68 patients (6%) developed solid kidney tumors; 3\/4 had a CDC73 variant at p.M1 residue. Parafibromin staining of parathyroid tumors did not correlate with tumor histology or genotype. RNA-sequencing showed a significant association of HPT-JT-related parathyroid tumors with transmembrane receptor protein tyrosine kinase signaling pathway, mesodermal commitment pathway, and cell-cell adhesion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Multiple, recurrent atypical adenomyomatous uterine polyps appear to be enriched in women with HPT-JT and appear characteristic of the disease. Patients with CDC73 variants at p.M1 residue appear predisposed to kidney tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial number<\/jats:title>\n                    <jats:p>NCT04969926<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgad368","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T16:49:14Z","timestamp":1687193354000},"page":"3165-3177","source":"Crossref","is-referenced-by-count":30,"title":["Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome"],"prefix":"10.1210","volume":"108","author":[{"given":"Rana","family":"Tora","sequence":"first","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Welch","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[{"name":"NIAID Collaborative Bioinformatics Resource (NCBR), National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, MD 20892 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita K","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra A","family":"Bell","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, MN 55905 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Merino","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7806-706X","authenticated-orcid":false,"given":"William F","family":"Simonds","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-3340","authenticated-orcid":false,"given":"Smita","family":"Jha","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"issue":"suppl 2","key":"2023111712391578700_dgad368-B1","first-page":"N12","article-title":"The epidemiology of primary hyperparathyroidism in North America","volume":"17","author":"Melton","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2023111712391578700_dgad368-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)","volume":"73","author":"Griebeler","year":"2015","journal-title":"Bone"},{"issue":"6","key":"2023111712391578700_dgad368-B3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.beem.2018.12.003","article-title":"Epidemiology of parathyroid disorders","volume":"32","author":"Rao","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11","key":"2023111712391578700_dgad368-B4","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2023111712391578700_dgad368-B5","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1210\/jc.2017-01249","article-title":"CDC73-related disorders: clinical manifestations and case detection in primary hyperparathyroidism","volume":"102","author":"van der Tuin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023111712391578700_dgad368-B6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-11-0003","article-title":"CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum","volume":"165","author":"Frank-Raue","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2023111712391578700_dgad368-B7","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French national cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023111712391578700_dgad368-B8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00423-009-0511-y","article-title":"Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred","volume":"394","author":"Iacobone","year":"2009","journal-title":"Langenbecks Arch Surg"},{"key":"2023111712391578700_dgad368-B9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","article-title":"Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumor syndrome","volume":"257","author":"Bradley","year":"2005","journal-title":"J Intern Med"},{"issue":"4","key":"2023111712391578700_dgad368-B10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"issue":"2","key":"2023111712391578700_dgad368-B11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","article-title":"The parafibromin tumor suppressor protein is part of a human Paf1 complex","volume":"25","author":"Rozenblatt-Rosen","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"12","key":"2023111712391578700_dgad368-B12","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1128\/MCB.25.12.5052-5060.2005","article-title":"The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II","volume":"25","author":"Yart","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2023111712391578700_dgad368-B13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jcp.2007.048694","article-title":"Parafibromin expression in breast cancer: a novel marker for prognostication?","volume":"61","author":"Selvarajan","year":"2008","journal-title":"J Clin Pathol"},{"issue":"2","key":"2023111712391578700_dgad368-B14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00428-007-0551-z","article-title":"Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas","volume":"452","author":"Zheng","year":"2008","journal-title":"Virchows Arch"},{"issue":"8","key":"2023111712391578700_dgad368-B15","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.humpath.2010.10.024","article-title":"Parafibromin expression is an independent prognostic factor for colorectal carcinomas","volume":"42","author":"Zheng","year":"2011","journal-title":"Hum Pathol"},{"issue":"2","key":"2023111712391578700_dgad368-B16","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1074\/jbc.M113.483255","article-title":"Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics","volume":"289","author":"Rather","year":"2014","journal-title":"J Biol Chem"},{"issue":"4","key":"2023111712391578700_dgad368-B17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson AG","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2023111712391578700_dgad368-B18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2006.02460.x","article-title":"Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours","volume":"64","author":"Bradley","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2023111712391578700_dgad368-B19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1677\/ERC-09-0272","article-title":"Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome","volume":"17","author":"Panicker","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"2023111712391578700_dgad368-B20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"2023111712391578700_dgad368-B21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"1","key":"2023111712391578700_dgad368-B22","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"issue":"20","key":"2023111712391578700_dgad368-B23","doi-asserted-by":"crossref","first-page":"11206","DOI":"10.3390\/ijms222011206","article-title":"Parathyroid tumors: molecular signatures","volume":"22","author":"Marini","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2023111712391578700_dgad368-B24","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.fertnstert.2012.08.017","article-title":"Aromatase inhibitor treatment of menorrhagia and subsequent pregnancy in a patient with familial hyperparathyroidism-jaw tumor syndrome","volume":"98","author":"Wolff","year":"2012","journal-title":"Fertil Steril"},{"key":"2023111712391578700_dgad368-B25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.urology.2018.11.013","article-title":"CDC73 Germline mutation in a family with mixed epithelial and stromal tumors","volume":"124","author":"Vocke","year":"2019","journal-title":"Urology"},{"issue":"2","key":"2023111712391578700_dgad368-B26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12022-016-9427-6","article-title":"A novel mutation in a patient with hyperparathyroidism-jaw tumour syndrome","volume":"27","author":"Bellido","year":"2016","journal-title":"Endocr Pathol"},{"issue":"23","key":"2023111712391578700_dgad368-B27","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1038\/sj.onc.1210131","article-title":"Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene","volume":"26","author":"Zhao","year":"2007","journal-title":"Oncogene"},{"issue":"6","key":"2023111712391578700_dgad368-B28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"issue":"1","key":"2023111712391578700_dgad368-B29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ijc.23876","article-title":"Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro","volume":"124","author":"Eskandarpour","year":"2009","journal-title":"Int J Cancer"},{"issue":"12","key":"2023111712391578700_dgad368-B30","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/2159-8290.CD-14-0729","article-title":"Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma","volume":"4","author":"Burd","year":"2014","journal-title":"Cancer Discov"},{"issue":"11","key":"2023111712391578700_dgad368-B31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc3106","article-title":"RAS oncogenes: weaving a tumorigenic web","volume":"11","author":"Pylayeva-Gupta","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2023111712391578700_dgad368-B32","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1349-7006.2008.00815.x","article-title":"Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells","volume":"99","author":"Cao","year":"2008","journal-title":"Cancer Sci"},{"issue":"5349","key":"2023111712391578700_dgad368-B33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1126\/science.279.5349.349","article-title":"Extension of life-span by introduction of telomerase into normal human cells","volume":"279","author":"Bodnar","year":"1998","journal-title":"Science"},{"issue":"2 Pt 1","key":"2023111712391578700_dgad368-B34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0092-8674(85)90170-9","article-title":"Identification of a specific telomere terminal transferase activity in tetrahymena extracts","volume":"43","author":"Greider","year":"1985","journal-title":"Cell"},{"issue":"6122","key":"2023111712391578700_dgad368-B35","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"issue":"6122","key":"2023111712391578700_dgad368-B36","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"issue":"12","key":"2023111712391578700_dgad368-B37","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/ijc.31731","article-title":"Suppression of PROX1-mediated TERT expression in hepatitis B viral hepatocellular carcinoma","volume":"143","author":"Kim","year":"2018","journal-title":"Int J Cancer"},{"key":"2023111712391578700_dgad368-B38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07918","article-title":"Cancer-associated TERT promoter mutations abrogate telomerase silencing","volume":"4","author":"Chiba","year":"2015","journal-title":"Elife"},{"issue":"23","key":"2023111712391578700_dgad368-B39","doi-asserted-by":"crossref","first-page":"19542","DOI":"10.18632\/oncotarget.4295","article-title":"The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"2023111712391578700_dgad368-B40","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1128\/MCB.00654-07","article-title":"Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice","volume":"28","author":"Wang","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"28","key":"2023111712391578700_dgad368-B41","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1038\/onc.2017.43","article-title":"Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome","volume":"36","author":"Walls","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"2023111712391578700_dgad368-B42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/09513590.2019.1653276","article-title":"Benign polypoid adenomyomatous endometrium associated with HPT-JT syndrome: a case report","volume":"36","author":"Arfi","year":"2020","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"2023111712391578700_dgad368-B43","article-title":"Ovarian granulosa cell tumor in A patient with A pathogenic variant in the CDC73 gene (hyperparathyroidism-jaw tumor syndrome)","volume":"5","author":"Sirbiladze","year":"2019","journal-title":"AACE Clin Case Rep"},{"issue":"5","key":"2023111712391578700_dgad368-B44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1530\/eje.0.1380557","article-title":"Familial isolated hyperparathyroidism due to multiple adenomas associated with ossifying jaw fibroma and multiple uterine adenomyomatous polyps","volume":"138","author":"Fujikawa","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023111712391578700_dgad368-B45","first-page":"40","article-title":"Endometrial polyps","volume":"8","author":"Peterson","year":"1956","journal-title":"Obstet Gynecol"},{"key":"2023111712391578700_dgad368-B46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.humpath.2018.10.002","article-title":"Clinicopathological and immunohistochemical features of uterine adenomyomatous polyps","volume":"84","author":"Strickland","year":"2019","journal-title":"Hum Pathol"},{"issue":"12","key":"2023111712391578700_dgad368-B47","first-page":"4204","article-title":"Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas","volume":"81","author":"Teh","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2023111712391578700_dgad368-B48","article-title":"Hyperparathyroidism jaw tumor syndrome presenting as recurrent femur fractures in a young woman; a rare presentation of a rare disease","volume":"2020","author":"Wijewickrama","year":"2020","journal-title":"Case Rep Endocrinol"},{"issue":"4","key":"2023111712391578700_dgad368-B49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4158\/EP10337.RA","article-title":"Familial hyperparathyroidism due to a germline mutation of the CDC73 gene: implications for management and age-appropriate testing of relatives at risk","volume":"17","author":"Pichardo-Lowden","year":"2011","journal-title":"Endocr Pract"},{"issue":"6","key":"2023111712391578700_dgad368-B50","first-page":"1006","article-title":"Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome","volume":"108","author":"Jackson","year":"1990","journal-title":"Surgery"},{"issue":"4","key":"2023111712391578700_dgad368-B51","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-49-4-829","article-title":"Hereditary hyperparathyroidism associated with recurrent pancreatitis","volume":"49","author":"Jackson","year":"1958","journal-title":"Ann Intern Med"},{"issue":"2","key":"2023111712391578700_dgad368-B52","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00268-019-05156-y","article-title":"Long-Term outcomes of parathyroidectomy in hyperparathyroidism-jaw tumor syndrome: analysis of five families with CDC73 mutations","volume":"44","author":"Iacobone","year":"2020","journal-title":"World J Surg"},{"issue":"7","key":"2023111712391578700_dgad368-B53","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab087","article-title":"Parafibromin abnormalities in ossifying fibroma","volume":"5","author":"Costa-Guda","year":"2021","journal-title":"J Endocr Soc"},{"issue":"1","key":"2023111712391578700_dgad368-B54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13000-016-0532-0","article-title":"CDC73 gene mutations in sporadic ossifying fibroma of the jaws","volume":"11","author":"Chen","year":"2016","journal-title":"Diagn Pathol"},{"issue":"7","key":"2023111712391578700_dgad368-B55","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.oraloncology.2005.11.019","article-title":"HRPT2 gene alterations in ossifying fibroma of the jaws","volume":"42","author":"Pimenta","year":"2006","journal-title":"Oral Oncol"},{"key":"2023111712391578700_dgad368-B56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1746-1596-9-75","article-title":"Two cases of multiple ossifying fibromas in the jaws","volume":"9","author":"Wang","year":"2014","journal-title":"Diagn Pathol"},{"issue":"9","key":"2023111712391578700_dgad368-B57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/ERC-20-0149","article-title":"Genotype of CDC73 germline mutation determines risk of parathyroid cancer","volume":"27","author":"Li","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"2023111712391578700_dgad368-B58","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jamcollsurg.2014.10.007","article-title":"Modern experience with aggressive parathyroid tumors in a high-volume New England referral center","volume":"220","author":"Quinn","year":"2015","journal-title":"J Am Coll Surg"},{"key":"2023111712391578700_dgad368-B59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/PAP.0b013e3180ca8ad0","article-title":"Parafibromin in the diagnosis of parathyroid carcinoma.pdf","volume":"14","author":"Mangray","year":"2007","journal-title":"Adv Anatomic Pathol"},{"issue":"2","key":"2023111712391578700_dgad368-B60","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","article-title":"Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas","volume":"21","author":"Kruijff","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2023111712391578700_dgad368-B61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2023111712391578700_dgad368-B62","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41379-019-0252-6","article-title":"Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center","volume":"32","author":"Juhlin","year":"2019","journal-title":"Mod Pathol"},{"issue":"12","key":"2023111712391578700_dgad368-B63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082292","article-title":"Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene","volume":"8","author":"Pazienza","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"2023111712391578700_dgad368-B64","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/nar\/gkp991","article-title":"The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression","volume":"38","author":"Yang","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"45","key":"2023111712391578700_dgad368-B65","doi-asserted-by":"crossref","first-page":"17420","DOI":"10.1073\/pnas.0710725105","article-title":"The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene","volume":"105","author":"Lin","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2023111712391578700_dgad368-B66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2006.08.169","article-title":"Parafibromin inhibits cancer cell growth and causes G1 phase arrest","volume":"350","author":"Zhang","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2023111712391578700_dgad368-B67","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/mc.20591","article-title":"The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA","volume":"49","author":"Farber","year":"2010","journal-title":"Mol Carcinog"},{"issue":"2","key":"2023111712391578700_dgad368-B68","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/1541-7786.MCR-06-0129","article-title":"Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function","volume":"5","author":"Lin","year":"2007","journal-title":"Mol Cancer Res"},{"issue":"3","key":"2023111712391578700_dgad368-B69","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1007\/s13277-015-4103-x","article-title":"The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy","volume":"37","author":"Shen","year":"2016","journal-title":"Tumour Biol"},{"issue":"1","key":"2023111712391578700_dgad368-B70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molcel.2011.05.014","article-title":"SHP2 tyrosine phosphatase converts parafibromin\/Cdc73 from a tumor suppressor to an oncogenic driver","volume":"43","author":"Takahashi","year":"2011","journal-title":"Mol Cell"},{"issue":"42","key":"2023111712391578700_dgad368-B71","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1038\/sj.onc.1210445","article-title":"Parafibromin tumor suppressor enhances cell growth in the cells expressing SV40 large T antigen","volume":"26","author":"Iwata","year":"2007","journal-title":"Oncogene"},{"issue":"2","key":"2023111712391578700_dgad368-B72","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2006.01.053","article-title":"Parafibromin\/Hyrax activates Wnt\/Wg target gene transcription by direct association with beta-catenin\/Armadillo","volume":"125","author":"Mosimann","year":"2006","journal-title":"Cell"},{"key":"2023111712391578700_dgad368-B73","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1038\/ncomms12887","article-title":"Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt\/Hedgehog\/Notch pathways","volume":"7","author":"Kikuchi","year":"2016","journal-title":"Nat Commun"},{"issue":"2","key":"2023111712391578700_dgad368-B74","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3892\/ijo.2014.2477","article-title":"Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation","volume":"45","author":"Lee","year":"2014","journal-title":"Int J Oncol"},{"issue":"1","key":"2023111712391578700_dgad368-B75","doi-asserted-by":"crossref","first-page":"15638","DOI":"10.1038\/s41598-017-15715-9","article-title":"Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome","volume":"7","author":"Sun","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"2023111712391578700_dgad368-B76","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1107\/S0907444912017325","article-title":"Crystallographic analysis of the conserved C-terminal domain of transcription factor Cdc73 from Saccharomyces cerevisiae reveals a GTPase-like fold","volume":"68","author":"Chen","year":"2012","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"14","key":"2023111712391578700_dgad368-B77","doi-asserted-by":"crossref","first-page":"10863","DOI":"10.1074\/jbc.M111.325647","article-title":"Cdc73 subunit of Paf1 complex contains C-terminal Ras-like domain that promotes association of Paf1 complex with chromatin","volume":"287","author":"Amrich","year":"2012","journal-title":"J Biol Chem"},{"issue":"26","key":"2023111712391578700_dgad368-B78","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1016\/j.febslet.2007.09.050","article-title":"Nucleolar localization of parafibromin is mediated by three nucleolar localization signals","volume":"581","author":"Hahn","year":"2007","journal-title":"FEBS Lett"},{"issue":"8","key":"2023111712391578700_dgad368-B79","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.onc.1209893","article-title":"Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal","volume":"26","author":"Bradley","year":"2007","journal-title":"Oncogene"},{"issue":"41","key":"2023111712391578700_dgad368-B80","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1038\/sj.onc.1208778","article-title":"Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin","volume":"24","author":"Hahn","year":"2005","journal-title":"Oncogene"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad368\/50820595\/dgad368.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/12\/3165\/53481046\/dgad368.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/12\/3165\/53481046\/dgad368.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T08:39:27Z","timestamp":1700210367000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/12\/3165\/7204091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":80,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6,20]]},"published-print":{"date-parts":[[2023,11,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad368","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,6,20]]}}}